Abstract: The invention described herein provides neutralizing antibodies against SARS-CoV-2 antigens (such as the S1 subunit of the S antigen) for use in treating human patients having COVID-19.

Abstract: The present invention concerns processes for barcoding nucleic acids from single cells and processes for genotyping ingle cells having a phenotype of interest.

Abstract: The present invention concerns processes for barcoding nucleic acids from single cells and processes for genotyping single cells having a phenotype of interest.

Abstract: The invention relates to a process for manufacturing a microfluidic chip comprising a solid material obtained from a sol-gel solution, the process comprising successively: a) casting a sol-gel solution made with tetraethyl orthosilicate onto a mold presenting a relief pattern and having a different thickness over the whole of the mold; b) gelling the sol-gel solution; c) unmolding and drying the gel obtained in b), so as to obtain a solid glass; and d) bonding said solid glass to a support, so as to obtain the microfluidic chip.

Abstract: The present invention concerns processes for barcoding nucleic acids from single cells and processes for genotyping single cells having a phenotype of interest.

Abstract: The present invention lies within the field of colloidal assemblies and relates to a system for producing solid clusters of microparticles, characterized in that it comprises at least: a fluidic device comprising at least: an element for producing primary droplets, comprising an outlet of width l1 and a main channel for forming solid clusters, having a main axis, of height h2 and comprising an inlet of width l2; said element for producing primary droplets being connected to said inlet of said main channel, h1 being less than h2, so as to form a step between said element for producing primary droplets and said main channel and l1 being strictly less than l2; a system of physical initiation of polymerization capable of initiating polymerization in said main channel.